@article{3807b665aa4340fcb94dd172cb2f8014,
title = "Cost-Utility of Using Alzheimer's Disease Biomarkers in Cerebrospinal Fluid to Predict Progression from Mild Cognitive Impairment to Dementia",
keywords = "Alzheimer's disease, cerebrospinal fluid, cost-utility, economic evaluation, mild cognitive impairment, prognosis, risk, ASSOCIATION WORKGROUPS, DIAGNOSTIC GUIDELINES, MODIFYING TREATMENT, NATIONAL INSTITUTE, RECOMMENDATIONS, CRITERIA, IMPACT",
author = "Handels, {Ron L. H.} and Anders Wimo and Richard Dodel and Kramberger, {Milica G.} and Visser, {Pieter Jelle} and {Luis Molinuevo}, Jose and Verhey, {Frans R. J.} and Bengt Winblad",
year = "2017",
month = nov,
day = "7",
doi = "10.3233/JAD-170324",
language = "English",
volume = "60",
pages = "1477--1487",
journal = "Journal of Alzheimer's Disease",
issn = "1387-2877",
publisher = "IOS Press",
number = "4",
}